1. Home
  2. FIEE vs IMRN Comparison

FIEE vs IMRN Comparison

Compare FIEE & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FIEE
  • IMRN
  • Stock Information
  • Founded
  • FIEE N/A
  • IMRN 1994
  • Country
  • FIEE United States
  • IMRN Australia
  • Employees
  • FIEE 43
  • IMRN N/A
  • Industry
  • FIEE Telecommunications Equipment
  • IMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FIEE Utilities
  • IMRN Health Care
  • Exchange
  • FIEE Nasdaq
  • IMRN Nasdaq
  • Market Cap
  • FIEE 15.6M
  • IMRN 14.4M
  • IPO Year
  • FIEE N/A
  • IMRN N/A
  • Fundamental
  • Price
  • FIEE $2.46
  • IMRN $2.20
  • Analyst Decision
  • FIEE
  • IMRN
  • Analyst Count
  • FIEE 0
  • IMRN 0
  • Target Price
  • FIEE N/A
  • IMRN N/A
  • AVG Volume (30 Days)
  • FIEE N/A
  • IMRN 95.9K
  • Earning Date
  • FIEE N/A
  • IMRN 08-29-2025
  • Dividend Yield
  • FIEE N/A
  • IMRN N/A
  • EPS Growth
  • FIEE N/A
  • IMRN N/A
  • EPS
  • FIEE N/A
  • IMRN N/A
  • Revenue
  • FIEE N/A
  • IMRN $4,777,422.00
  • Revenue This Year
  • FIEE N/A
  • IMRN N/A
  • Revenue Next Year
  • FIEE N/A
  • IMRN N/A
  • P/E Ratio
  • FIEE N/A
  • IMRN N/A
  • Revenue Growth
  • FIEE N/A
  • IMRN 48.63
  • 52 Week Low
  • FIEE N/A
  • IMRN $1.50
  • 52 Week High
  • FIEE N/A
  • IMRN $2.48
  • Technical
  • Relative Strength Index (RSI)
  • FIEE 37.10
  • IMRN 58.40
  • Support Level
  • FIEE $2.34
  • IMRN $2.09
  • Resistance Level
  • FIEE $2.49
  • IMRN $2.24
  • Average True Range (ATR)
  • FIEE 0.16
  • IMRN 0.14
  • MACD
  • FIEE -0.01
  • IMRN -0.01
  • Stochastic Oscillator
  • FIEE 27.91
  • IMRN 55.00

About FIEE FiEE Inc Common Stock

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: